Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of Isotoxic Accelerated Radiotherapy in the Treatment of Patients With Non-small Cell Lung Cancer

NCT01537991 is registered in ClinicalTrials.gov with Lisette Nixon as lead sponsor.

NCT NCT01537991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01537991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of Isotoxic Accelerated Radiotherapy in the Treatment of Patients With Non-small Cell Lung Cancer
Lead sponsor
Lisette Nixon
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2012
Completion date
December 31, 2018
Enrollment
81 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced non-small cell lung cancer